According to Harvard Bioscience's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.58. At the end of 2025 the company had a P/S ratio of 0.2942.
Year | P/S ratio | Change |
---|---|---|
2025 | 0.2942 | -67.94% |
2024 | 0.9174 | -54.91% |
2023 | 2.03 | 99.83% |
2022 | 1.02 | -58.26% |
2021 | 2.44 | 47.33% |
2020 | 1.66 | 65.16% |
2019 | 1.00 | 1.87% |
2018 | 0.9842 | -28.84% |
2017 | 1.38 | 37.89% |
2016 | 1.00 | -7.56% |
2015 | 1.09 | -36.14% |
2014 | 1.70 | 20.17% |
2013 | 1.41 | 22.16% |
2012 | 1.16 | 14.25% |
2011 | 1.01 | -5.12% |
2010 | 1.07 | -13.28% |
2009 | 1.23 | 33.11% |
2008 | 0.9251 | -45.39% |
2007 | 1.69 | -18.16% |
2006 | 2.07 | 2.98% |
2005 | 2.01 | 22.69% |
2004 | 1.64 | -46.76% |
2003 | 3.08 | 78.3% |
2002 | 1.73 | -73.4% |
2001 | 6.49 |